Proposed Medicare $2 Drug List Model May Only Offer Modest Savings
-
Oct 10, 2024
CMS on Oct. 9 released a request for information and sample list of medications that could be part of the Medicare $2 Drug List Model, which the agency first floated last year to help lower the cost of common generic medications for beneficiaries with chronic conditions. However, a recent analysis published in JAMA Internal Medicine found the model may only lead to modest savings and impact fewer than 40% of enrollees.
While Christopher L. Cai, M.D., the study’s lead author, tells AIS Health he was “initially surprised” by the results, he notes the model is voluntary, so CMS is in a bind because it needs to design a program that saves money for members but is also attractive to plan sponsors.
Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.